SYNTHESIS AND PHARMACOLOGICAL EFFECTS OF OPTICALLY-ACTIVE 2-[4-(4-BENZHYDRYL-1-PIPERAZINYL)PHENYL]ETHYL METHYL 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLATE HYDROCHLORIDE

被引:0
|
作者
ASHIMORI, A [1 ]
UCHIDA, T [1 ]
OHTAKI, Y [1 ]
TANAKA, M [1 ]
OHE, K [1 ]
FUKAYA, C [1 ]
WATANABE, M [1 ]
KAGITANI, M [1 ]
YOKOYAMA, K [1 ]
机构
[1] GREEN CROSS CO, DIV RES, 1180-1 SHODAIOTANI 2 CHOME, HIRAKATA, OSAKA 573, JAPAN
关键词
1,4-DIHYDROPYRIDINE; CALCIUM ANTAGONIST; ANTIHYPERTENSIVE EFFECT; RECEPTOR BINDING ASSAY; OPTICALLY ACTIVE COMPOUND; AE0047;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Optically active 2-[4-(4-benzhydryl-1-piperazinyl)phenyl]ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate [(S)-(+)-1 and (R)-(-)-1] hydrochlorides were synthesized with high optical purities from (R)-(-)- and (S)-(+)-1,4-dihydro-5-methoxycarbonyl-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridinecarboxylic acids [(R)-(-)-6 and (S)-(+)-6], which are available from (+/-)-6 by optical resolution using quinidine and cinchondine, respectively. From pharmacological investigations of (S)-(+)-1 and (R)-(-)-1 such as the antihypertensive effect on spontaneously hypertensive rats and inhibition of [H-3]nimodipine binding to rat cardiac membrane homogenate, the active form of 1 was defined to be the (4S)-(+)-enantiomer of 1.
引用
收藏
页码:108 / 111
页数:4
相关论文
共 50 条